These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2468440)

  • 1. Lung metabolism of xenobiotic compounds.
    Duncan CA
    Clin Chest Med; 1989 Mar; 10(1):49-58. PubMed ID: 2468440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the lung in accumulation and metabolism of xenobiotic compounds--implications for chemically induced toxicity.
    Foth H
    Crit Rev Toxicol; 1995; 25(2):165-205. PubMed ID: 7612175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancer.
    Petros WP; Broadwater G; Berry D; Jones RB; Vredenburgh JJ; Gilbert CJ; Gibbs JP; Colvin OM; Peters WP
    Clin Cancer Res; 2002 Mar; 8(3):698-705. PubMed ID: 11895898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics.
    Cagnoni PJ; Matthes S; Day TC; Bearman SI; Shpall EJ; Jones RB
    Bone Marrow Transplant; 1999 Jul; 24(1):1-4. PubMed ID: 10435726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury.
    Kachel DL; Martin WJ
    J Pharmacol Exp Ther; 1994 Jan; 268(1):42-6. PubMed ID: 8301583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and effects of alpha-melanocyte-stimulating hormone during acute lung injury.
    Colombo G; Gatti S; Sordi A; Turcatti F; Carlin A; Rossi C; Lonati C; Catania A
    Shock; 2007 Mar; 27(3):326-33. PubMed ID: 17304115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of alkylating agents.
    Lind MJ; Ardiet C
    Cancer Surv; 1993; 17():157-88. PubMed ID: 8137340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary toxicity of drugs and thoracic irradiation in children].
    Fauroux B; Clément A; Tournier G
    Rev Mal Respir; 1996 Jul; 13(3):235-42. PubMed ID: 8765915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of genomic damage caused by 5-nitrofurantoin in young and adult mice using the in vivo micronucleus assay.
    Fucić A; Marković D; Ferencić Z; Mildner B; Jazbec AM; Spoljar JB
    Environ Mol Mutagen; 2005 Jul; 46(1):59-63. PubMed ID: 15880513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrofurantoin-stimulated oxidant production in pulmonary endothelial cells.
    Martin WJ; Powis GW; Kachel DL
    J Lab Clin Med; 1985 Jan; 105(1):23-9. PubMed ID: 2981942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine.
    Nici L; Santos-Moore A; Kuhn C; Calabresi P
    Cancer; 1998 Nov; 83(9):2008-14. PubMed ID: 9806661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nitrofurantoin on the glutathione redox status and related enzymes in the isolated, perfused rabbit lung.
    Dunbar JR; DeLucia AJ; Bryant LR
    Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):485-92. PubMed ID: 7323444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibitors of cytochromes P450.
    Halpert JR; Guengerich FP; Bend JR; Correia MA
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):163-75. PubMed ID: 8171425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Azoulay E; Herigault S; Levame M; Brochard L; Schlemmer B; Harf A; Delclaux C
    Crit Care Med; 2003 May; 31(5):1442-8. PubMed ID: 12771616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain.
    Fung LK; Ewend MG; Sills A; Sipos EP; Thompson R; Watts M; Colvin OM; Brem H; Saltzman WM
    Cancer Res; 1998 Feb; 58(4):672-84. PubMed ID: 9485020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between drug metabolism genotype, chemotherapy pharmacokinetics, and overall survival in patients with breast cancer.
    Petros WP; Hopkins PJ; Spruill S; Broadwater G; Vredenburgh JJ; Colvin OM; Peters WP; Jones RB; Hall J; Marks JR
    J Clin Oncol; 2005 Sep; 23(25):6117-25. PubMed ID: 16087946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children.
    Karpman E; Kurzrock EA
    J Urol; 2004 Aug; 172(2):448-53. PubMed ID: 15247700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of vitamin A deficiency on surfactants and enzymes of xenobiotic metabolism in the rat lung].
    Iakovleva OA; Pentiuk AA; Gutsol VI; Bogdanov NG
    Vopr Pitan; 1987; (4):61-3. PubMed ID: 3673017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of alpha-lipoic acid on bleomycin-induced pulmonary fibrosis in rats.
    Liu R; Ahmed KM; Nantajit D; Rosenthal FS; Hai CX; Li JJ
    Int J Mol Med; 2007 Jun; 19(6):865-73. PubMed ID: 17487418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary toxicity of free radicals of oxygen].
    Housset B; Junod A
    Rev Fr Mal Respir; 1983; 11(1):3-17. PubMed ID: 6189156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.